Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more) AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Bruker Corporation BRKR

Alternate Symbol(s):  BRKRP

Healthcare Biotechnology
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic... see more

Recent & Breaking News (NDAQ:BRKR)

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

Business Wire 6 days ago

Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

Business Wire 9 days ago

Bruker Introduces iNTApharma(TM), a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

Business Wire 9 days ago

Bruker Announces Quarterly Preferred Stock Dividend

Business Wire 12 days ago

Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast

Business Wire 13 days ago

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

Business Wire January 9, 2026

Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

Business Wire January 8, 2026

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

Business Wire January 7, 2026

RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

Business Wire December 22, 2025

Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions

Business Wire December 10, 2025

Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026

Business Wire December 8, 2025

Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend

Business Wire November 4, 2025

Bruker Reports Third Quarter 2025 Financial Results

Business Wire November 3, 2025

Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast

Business Wire October 22, 2025

Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University

Business Wire October 3, 2025

Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock

Business Wire September 3, 2025

Levi & Korsinsky Announces an Investigation on Behalf of Bruker Corporation (BRKR) Shareholders Who May Have Been Affected by Fraud

ACCESS Newswire September 3, 2025

Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock

Business Wire September 2, 2025

Bruker Corporation Being Investigated on Behalf of Bruker Corporation Investors. Contact Levi & Korsinsky For Details

ACCESS Newswire September 2, 2025

Bruker Corporation (BRKR) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates

ACCESS Newswire August 28, 2025

Podcasts